PREDIERI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 35.803
EU - Europa 29.841
AS - Asia 19.382
SA - Sud America 2.405
Continente sconosciuto - Info sul continente non disponibili 851
AF - Africa 500
OC - Oceania 184
Totale 88.966
Nazione #
US - Stati Uniti d'America 34.862
IT - Italia 13.710
SG - Singapore 6.365
GB - Regno Unito 4.972
CN - Cina 4.772
SE - Svezia 3.484
HK - Hong Kong 2.297
DE - Germania 1.778
BR - Brasile 1.725
VN - Vietnam 1.704
FI - Finlandia 1.239
FR - Francia 1.017
BD - Bangladesh 940
UA - Ucraina 801
RU - Federazione Russa 719
KR - Corea 589
TR - Turchia 587
IN - India 550
CA - Canada 474
NL - Olanda 406
ID - Indonesia 316
BG - Bulgaria 307
JP - Giappone 225
AR - Argentina 210
MX - Messico 210
ES - Italia 198
IE - Irlanda 192
CH - Svizzera 158
PL - Polonia 153
AU - Australia 146
PK - Pakistan 146
ZA - Sudafrica 146
IQ - Iraq 143
EC - Ecuador 116
IR - Iran 97
BE - Belgio 94
EG - Egitto 91
LT - Lituania 90
MY - Malesia 84
AT - Austria 82
VE - Venezuela 80
DK - Danimarca 79
CO - Colombia 77
BZ - Belize 75
AE - Emirati Arabi Uniti 72
CL - Cile 65
CZ - Repubblica Ceca 55
PH - Filippine 54
TH - Thailandia 54
PT - Portogallo 47
RO - Romania 46
SA - Arabia Saudita 46
UZ - Uzbekistan 46
MA - Marocco 45
PE - Perù 45
PY - Paraguay 41
TW - Taiwan 40
GR - Grecia 37
NZ - Nuova Zelanda 37
DZ - Algeria 36
JO - Giordania 36
TN - Tunisia 36
NP - Nepal 35
KE - Kenya 32
IL - Israele 31
CR - Costa Rica 30
JM - Giamaica 29
ET - Etiopia 27
AZ - Azerbaigian 23
BO - Bolivia 22
RS - Serbia 22
HU - Ungheria 21
AL - Albania 19
DO - Repubblica Dominicana 19
NG - Nigeria 18
HN - Honduras 17
KZ - Kazakistan 17
UG - Uganda 16
UY - Uruguay 16
GT - Guatemala 15
NO - Norvegia 15
EU - Europa 13
NI - Nicaragua 13
PA - Panama 13
SM - San Marino 13
KW - Kuwait 11
OM - Oman 11
SV - El Salvador 11
CY - Cipro 10
EE - Estonia 10
SI - Slovenia 10
TT - Trinidad e Tobago 10
LB - Libano 9
SK - Slovacchia (Repubblica Slovacca) 9
AM - Armenia 8
GE - Georgia 8
LV - Lettonia 8
MT - Malta 8
PR - Porto Rico 8
PS - Palestinian Territory 8
Totale 87.959
Città #
Singapore 4.277
Ashburn 3.404
Santa Clara 3.351
Southend 3.321
Fairfield 2.256
Hong Kong 2.216
San Jose 1.961
Stockholm 1.810
Chandler 1.625
Woodbridge 1.604
Houston 1.577
Hefei 1.418
Jacksonville 1.369
Dearborn 1.131
Milan 1.106
Council Bluffs 1.008
Rome 1.004
Helsinki 939
Nyköping 888
Ann Arbor 859
Seattle 856
London 855
Beijing 846
Wilmington 817
Cambridge 693
New York 620
Los Angeles 595
Seoul 539
Ho Chi Minh City 525
The Dalles 518
Naples 417
Hanoi 385
Munich 377
Bologna 371
Chicago 329
Princeton 325
Lauterbourg 294
Sofia 287
Modena 285
Palermo 270
Buffalo 266
San Diego 255
Eugene 254
Turin 244
Columbus 223
Shanghai 223
Jakarta 220
Dallas 219
Redwood City 217
Moscow 214
Izmir 208
Orem 196
Frankfurt am Main 195
Bremen 187
Bari 186
São Paulo 167
Florence 159
Dublin 152
Catania 146
Boardman 143
Tokyo 133
Toronto 123
Padova 121
Verona 120
Parma 109
Chennai 98
Fremont 98
Des Moines 97
Phoenix 97
Salt Lake City 96
Warsaw 96
Montreal 95
Johannesburg 94
Las Vegas 92
Da Nang 87
Atlanta 81
Albuquerque 80
Genoa 79
Guangzhou 78
Tampa 78
Amsterdam 75
Belize City 74
Brescia 74
Haiphong 72
Nuremberg 71
Falls Church 70
Brooklyn 67
Mexico City 66
Denver 65
Mumbai 63
Pescara 62
Dong Ket 61
Nanjing 61
Paris 61
Rio de Janeiro 61
Turku 59
Cagliari 56
Poplar 55
Redondo Beach 55
Cairo 53
Totale 54.635
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 4.968
"Balanced translocation" T(3;11)(P21;Q13) in a lipoma from a girl with suspected MEN 1 Syndrome. 2.006
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.203
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 1.202
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 949
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 859
Gestione del Covid-19 in età pediatrica: documento di consenso 794
Effetti degli interferenti endocrini su crescita e sviluppo puberale 708
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 658
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 650
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 534
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 497
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 496
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 480
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 430
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 425
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 421
High basal serum allopregnanolone levels in overweight girls 414
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 396
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 395
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 394
Endothelial and heart dysfunction in children and adolescents with type 1 diabetes 392
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 391
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 390
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 389
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 389
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 388
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 386
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 385
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 383
Childhood obesity and environmental pollutants: a dual relationship 381
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 380
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 376
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 371
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 370
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 368
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 368
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 368
L’ipercolesterolemia familiare: terapia farmacologica 351
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 348
Low serum allopregnanolone levels in girls with precocious pubarche 346
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 343
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes 342
Brain-derived neurotrophic factor and epilepsy: a systematic review 341
Approaches to dyslipidemia treatment in children and adolescents 339
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 337
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 325
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 323
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 317
The Role of Nutrition on Thyroid Function 313
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 312
Endocrine immune-related adverse effects of immune-checkpoint inhibitors 310
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 310
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 309
COVID-19 and Type 1 Diabetes: Concerns and Challenges 309
Prevalence and risk factors for microalbuminuria in children and adolescents with type 1 diabetes: long-term experience of a single centre 306
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 304
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 304
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study 303
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 302
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 300
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 300
Obesity in pediatric age: The analysis of genomic rearrangements 299
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 297
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 296
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 295
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 295
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 294
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 294
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 293
Health-related quality of life and metabolic control in young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown 293
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 292
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 290
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 289
Endocrine Disrupting Chemicals and Type 1 Diabetes 286
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 284
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. 280
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 280
Endocrine-disrupting chemicals and their effects during female puberty: A review of current evidence 280
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 279
MicroRNAs change and target key regulatory genes involved in longitudinal growth in patients with idiopathic isolated growth hormone deficiency (IGHD) on growth hormone (GH) treatment 278
Efficacy of telemedicine in patients with type 1 diabetes over the second year by the COVID-19 pandemic spread 277
Low-density lipoprotein oxidizability in children with chronic renal failure 277
Hypercholesterolemia in Childhood 277
Markers of Inflammation and Endothelial Dysfunction in Young Survivors from Acute Lymphoblastic Leukemia 277
Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency 276
Health-Related Quality of Life and Diabetes Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 276
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 275
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 275
Human amniotic epithelial cells (HAECs): a reliable source of insulin producing cells? 275
A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes 275
Auxological data and glycemic control in children and adolescents with type 1 diabetes 2-years after the COVID-19 pandemic 274
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 274
Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene. 272
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 272
Tracheobronchial anomalies in chromosome 22q11.2 microdeletion 270
Confocal microscopy: Improving our understanding of nevogenesis 270
Evaluation and management of hyperlipidemia in children and adolescents. 269
Impaired GH Secretion in Patients with SHOX Deficiency and Efficacy of Recombinant Human GH Therapy. 269
Perinatal exposure to phthalates: From endocrine to neurodevelopment effects 268
Totale 43.740
Categoria #
all - tutte 291.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 291.623


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.846 0 655 466 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/202515.136 572 469 440 1.066 2.521 2.130 1.193 874 1.973 920 1.335 1.643
2025/202628.565 1.631 972 2.031 2.832 3.901 2.037 3.590 1.304 3.980 2.516 2.041 1.730
2026/20272.603 1.168 1.435 0 0 0 0 0 0 0 0 0 0
Totale 88.966